Saturday, May 30, 2020

The paradox of population health: Focus on personalized support for the greatest impact

Employees
Abraham Maslow said in 1966, “I suppose it is tempting, if the only tool you have is a hammer, to treat everything as if it were a nail.” This mentality — known as the Law of the Instrument — indicates that people tend to rely on the tool with which they are most...

Infinet Wireless solutions boost provision of healthcare to the most vulnerable in South American city

Infinet Wireless solutions boost provision of healthcare to the most vulnerable in South American city
Wireless networks allow healthcare administration to deliver better services, catering especially to vulnerable patients Number of people attended to daily by health professionals increases five-fold Cartagena, Colombia, 26th May 2020 – Infinet Wireless, the global leader in fixed broadband wireless connectivity, has helped significantly improve the ability of a major South American...

COVID-19: a technologist’s tale | Healthcare IT News

COVID-19 has been deadly, it’s infective and has posed the biggest public health risk to society in almost a hundred years. It’s far from over and whilst the first wave may have occurred there are likely to be subsequent waves which may arrive in the winter months if not sooner. So far we...

Navigating disruption and preparing for new opportunities: 4 strategies for medtech leaders

Seasoned medtech leaders have typically seen their companies through historic disruptions requiring rapid shifts in production, realignment of deliverables, reallocation of raw materials, and more. Whether this was in response to natural disasters, trade disputes, or some other significant disruption, experienced executive teams with well-devised contingency plans have traditionally managed to move forward...

Fitness App Strava Is Offering A 60-Day Trial To Its New Subscription Offering

Strava, the GPS tracker app and social network for sharing your sporting endeavours, is exceptionally popular in the serious (and not so serious) running and cycling communities. Today it announced some significant changes to what is and isn’t free, moving a fundamental part of the experience – segment leaderboards – behind a...

Wyld Networks works with NHS Highland and Highland Health Ventures to integrate mesh technology into new mobile app to help prevent spread of COVID-19 in care homes

Alastair Williamson
Specialist app will provide safer environments and better communications by creating geozones20 May 2020: Wyld Networks has signed an agreement with Highland Health Ventures Ltd (HHVL) to test and deploy its mobile mesh technology into care homes in Scotland to help protect residents, staff and visitors and prevent the spread...

The barriers to health data exchange that are exacerbating the coronavirus pandemic

We have been watching the statistics for more than weeks now. We watch with a sense of disbelief, horror, sorrow, hope, disgust, and impatience. We hear about the number of tests performed, positive tests, negative tests, confirmed cases, number of individuals who have recovered, and deaths. We have heard new terms like social...

Large Tennessee insurer makes telehealth coverage permanent

As more patient visits take place online during the Covid-19 pandemic, most commercial insurers have expanded their telehealth coverage. Now, healthcare providers are waiting to see if those changes will last. Tennessee’s largest commercial insurer was one of the first to signal its continued coverage of telehealth. Last week, it updated its plans to...

The Saucony Rival To The Nike Vaporfly Is Now Available In The UK

It’s a curious time for running, with many of the biggest brands releasing the most exciting racing shoes in years into a world where no-one can actually race. However, racing will return one day, and when it does people will have the best ever selection of shoes with carbon plates in the...

J&J drug produces responses in more than 1/3 of myeloma patients in ASCO data

Early data on a bispecific monoclonal antibody for multiple myeloma show that patients receiving it achieved deep and persistent responses to therapy, while the safety profile was described as manageable, the company developing it said Monday. Johnson & Johnson’s Raritan, New Jersey-based subsidiary, Janssen Pharmaceutical Companies, announced data from the Phase I dose-escalation study...
0FansLike
0FollowersFollow

Must Read